French pharmaceutical giant Sanofi recently announced that the US Food and Drug Administration (FDA) has approved the nanobody drug Cablivi (caplacizumab), combined with plasma exchange and immunosuppressive therapy. For the treatment ofRead More…
Immunity Shortcut to Reconstruct Key HIV Broadly Neutralizing Antibody Production Is Revealed
The human immunodeficiency virus (HIV) evades the body’s immune defenses through multiple mutations, and antibodies produced by the host immune system against HIV follow complex and untraceable evolutionary pathways. This complexity makesRead More…
Development Status Analysis of Global Tumor Immunotherapy Industry
Immuno-Oncology Therapy (I-O) refers to a therapy that kills tumor cells by activating the body’s immune system. According to their different mechanisms of action, immunotherapeutic drugs can be divided into six categories.Read More…
Immunity：New Antibody Breakthrough to Lead the Fight Against Cancers
In a recent study published in an international magazine of Immunity, scientists at the University of Southampton have developed a new antibody that could hold the key to unlocking cancers’ defense againstRead More…
Science Advances: The Structure of Antibody IgM Is Redefined
In a new study, researchers from the University of Tokyo in Japan revealed the structure of a immune protein called immunoglobulin M (IgM) by using computer image analysis and electron microscopy imaging.Read More…
Three Scientists from US and UK Shared the 2018 Nobel Prize in Chemistry
On October 3rd, the 2018 Nobel Prize in Chemistry was awarded to the field of biochemistry, in which Frances H. Arnold of US won half in recognition of her directed evolution ofRead More…
Overview of Four Progresses in Antibody Fields
1. DotBio announced the establishment of a next-generation immuno-oncology drug based on domain antibody DotBio, a new company focused on the development of new anti-tumor drugs for humanized antibodies, has officially announcedRead More…
CA: Big Data Analysis Over 85 Years in Anti-cancer Field
The International Union Against Cancer believes that one-third of cancers are preventable, one-third can be cured if diagnosed early, and one-third can be alleviated to help prolong patients’ life. Cancer control isRead More…
First Approval for Erenumab
On May 17, 2018, the U.S. Food and Drug Administration approved erenumab-aooe (Aimovig) for the preventive treatment of migraine in adults. Erenumab is a human monoclonal antibody that targets calcitonin gene-related peptide (CGRP) receptor,Read More…
Combination of Immune Cells Improves Chances of Successful Immunotherapy
Immunotherapy with checkpoint inhibitors is more effective in cancer patients who have elevated numbers of specific types of immune cells inside their tumors, a study suggests. Patients with a favorable combination of immuneRead More…